Novozymes chooses GEA technology for a new functional protein plant in US

GEA will build Novozymes’ new plant to produce alternative products for the human nutrition turnkey. This order in the growing “New Food” market is one of the largest orders in the company’s history.

Photo - GEA

Novozymes chooses GEA technology for a new functional protein plant in US

Order value well into the high double-digit million-euro range

Novozymes, the world’s largest supplier of enzyme and microbial technologies headquartered in Denmark, has entrusted GEA with the turnkey fitting of a major new plant to produce plant-based proteins for the plant-based food industry. The volume of this order is well into the high double-digit million-euro range.

GEA is further expanding its market position in the dynamically growing new food market with one of the biggest orders in its history. Novozymes, the world’s largest supplier of enzyme and microbial technologies headquartered in Denmark, has entrusted GEA with the turnkey fitting of a major new plant to produce plant-based proteins for the plant-based food industry. The volume of this order is well into the high double-digit million-euro range. Building the new factory in Nebraska, USA, will start later this year and is expected to be completed towards the end of 2023.

GEA, chief executive officer Stefan Klebert, says, “The demand for foods that have a demonstrably lower environmental footprint than conventionally produced products is growing enormously. With our technologies and experience in scaling industrial applications, GEA is ideally positioned to serve the new food market and thus contribute to our corporate purpose of ‘engineering for a better world’. We are pleased to partner with Novozymes in this strategic project.”

<div class="paragraphs"><p>GEA will build Novozymes’ new plant to produce alternative products for the human nutrition turnkey. This order in the growing “New Food” market is one of the largest orders in the company’s history.</p></div>
GEA's fortunate cooperation with India's Fortune Dairy

For decades, Novozymes has been developing fermented catalytic (industrially produced) proteins – enzymes – that are the basis for many industrial applications. Only recently, the company announced its intention to invest DKK 2 billion in the growth market for functional proteins (advanced protein solutions) for the food industry. “This investment in a new, state-of-the-art production line in Blair, Nebraska, underscores our commitment to feeding the world sustainably and demonstrating the true strength of biotechnology,” says chief operating officer and executive vice president Graziela Chaluppe dos Santos Malucelli, Novozymes.

The new plant covers the manufacturing steps from harvesting to the separation of proteins. According to Heinz-Jürgen Kroner, senior vice president of Liquid Technologies at GEA and responsible for the company’s alternative foods business, both partners are united by their ability to build scalable, reliable, and highly efficient plant systems. “This project is exceptional in many respects. The intensive bidding phase saw us planning the production lines for the ingredients less than a year later, and we now aim to implement the project at the same pace. The partnership is a very rewarding experience.”

GEA will now construct the process systems, including membrane filters, mixers, homogenizers, heat exchangers, pasteurizers and UHT units, cleaning and filling systems, and pump and valve technology. The installation will start in mid-2022. The production capacity initially built can easily be expanded to multiply the capacity in the future as demand grows.

Related Stories

No stories found.